WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):
-Earnings: -$200.29 million in Q1 vs. -$182.22 million in the same period last year. -EPS: -$1.71 in Q1 vs. -$1.62 in the same period last year. -Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of -$191.62 million or -$1.64 per share for the period. -Analysts projected -$1.75 per share -Revenue: $135.77 million in Q1 vs. $71.94 million in the same period last year.
Copyright RTT News/dpa-AFX